Guggenheim Capital LLC I Teos Therapeutics, Inc. Transaction History

Guggenheim Capital LLC

  • $14 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$10.95 - $14.6 $7,183 - $9,577
656 Added 5.85%
11,861 $129,000
Q2 2023

Aug 11, 2023
BUY
$12.93 - $18.05 $5,857 - $8,176
453 Added 4.21%
11,205 $148,000
Q1 2023

May 10, 2023
SELL
$13.02 - $22.62 $139,730 - $242,757
-10,732 Reduced 49.95%
10,752 $146,000
Q4 2022

Feb 14, 2023
BUY
$17.77 - $21.6 $381,770 - $464,054
21,484 New
21,484 $419,000

Others Institutions Holding ITOS

# of Institutions
166
Shares Held
36.6M
Call Options Held
1.95M
Put Options Held
374K
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $257M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email